-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_appendixes.pdf
October 06, 2006 - Template for Draft Reports
Appendix A: Search Strategies
Appendix A: Search Strategies
DIALOG MEDLINE®/EMBASE Search. Run on August 3, 2006
TOTAL = 3080
MEDLINE® = 1576
EMBASE = 1504 unique records
EMBASE terminology is in bold
s1
dt=randomized controlled trial OR randomized controlled tria…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-treatment-appendices-11-5-10-2.pdf
October 27, 2009 - APPENDIX A1. MEDICATIONS FDA APPROVAL STATUS
Pharmacologic category Generic Name US Brand Name FDA Status
Approval
Date
Marketing
Status
Non-selective beta-adrenergic receptor
blocker Timolol Betimol®
Approved - NDA
020439 3/31/1995 Prescription
Istalol®
Approved - NDA
021516 06/04/2004 Pres…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharm-ptsd-update-appendix-f-1.xlsx
January 01, 2019 - F-1. ROB Assessment
Table F-1. Risk of bias assessment
Author, Year
Selection Bias:
Randomization adequate? Selection Bias:
Allocation concealment adequate? Selection Bias:
Groups similar at baseline?
Selection Bias:
ITT analysis? Performance Bias:
Care providers masked? Performance Bias:
Patients masked? Detection…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
August 01, 2016 - Omega−3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review
Context and Purpose of Review
The value of omega 3 fatty acids (n-3 FA) intake to improve cardiovascular outcomes and risk
factors remains controversial. This review updates prior Evidence Reports on this topic. The n-3
FA under review in…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
May 16, 2013 - Source: www.effectivehealthcare.ahrq.gov
Published online: May 16, 2013
CER # 15:
Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
Original release date
July 6, 2009
Surveillance Report (1st Assessment/cycle 1)
November, 2011
Surveillance Report (2nd Assessment/cycle 2)…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendices.pdf
May 22, 2024 - Appendixes: Blood-based Tests for Multiple Cancer Screening: A Systematic Review
Appendix A. Methods
Inclusion and Exclusion Criteria
Table A-1. Detailed inclusion and exclusion criteria for systematic review on blood-based tests for
multiple cancer screening
PICOTS Inclusion Criteria Exclusion Criteria
Popula…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/Masks-appendix-table-b-1-surveillance-report.xlsx
April 09, 2020 - B-1. RCTs Mask Use
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table B-1. Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source Link/URL Study Design Objectives Study Da…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-1-version-1.xlsx
April 09, 2020 - Appendix Table B-1. RCTs of Masks
B-1. RCTs Mask Use
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table B-1. Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source Link/U…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
April 09, 2020 - B-1. RCTs Mask Use
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table A-1. Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source Link/URL Study Design Objectives Study Da…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/masks-appendix-table-b-1-version-2.xlsx
April 09, 2020 - B-1. RCTs Mask Use
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table B-1. Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source Link/URL Study Design Objectives Study Da…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_surveillance.pdf
April 01, 2016 - Treatment Resistant Depression Surveillance FINAL
AHRQ Systematic Review
Surveillance Program
CER #33: …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes.pdf
April 01, 2005 - Draft Comparative Effectiveness Review Appendicies
Appendix A. Search Strategy
MEDLINE 1966-August Week 4 2005
# Search History Results
1 exp Hypertension, Renal/ 15140
2 exp Renal Artery Obstruction/ 7388
3 renal arter$ stenosis.tw. 3264
4 renal arter$ dis$.tw. 390
5 renovascular dis$.tw. 613
6 reno vasc…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/hip-fracture-pain_surveillance.pdf
July 08, 2015 - Surveillance Report: CER 30: Comparative Effectiveness of Pain Management for Hip Fracture
AHRQ Comparative Effectiveness Review
Surveillance Program
CER #30: Comparative Effectiveness of Pain Management
Interventions for Hip Fracture …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
January 01, 2023 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
January 01, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
January 01, 2024 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/plant-based-treatments-draft-report-2025-rct-table-app-e.xlsx
January 01, 2025 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…